Russell Investments Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,121
| Closed | -$120K | – | 3680 |
|
|
2023
Q2 | $120K | Sell |
3,121
-15,571
| -83% | -$598K | ﹤0.01% | 2570 |
|
|
2023
Q1 | $433K | Buy |
18,692
+3,301
| +21% | +$76.4K | ﹤0.01% | 2306 |
|
|
2022
Q4 | $403K | Hold |
15,391
| – | – | ﹤0.01% | 2351 |
|
|
2022
Q3 | $302K | Hold |
15,391
| – | – | ﹤0.01% | 2426 |
|
|
2022
Q2 | $269K | Hold |
15,391
| – | – | ﹤0.01% | 2475 |
|
|
2022
Q1 | $251K | Sell |
15,391
-2,458
| -14% | -$40.1K | ﹤0.01% | 2414 |
|
|
2021
Q4 | $291K | Buy |
17,849
+2,458
| +16% | +$40.1K | ﹤0.01% | 2618 |
|
|
2021
Q3 | $196K | Hold |
15,391
| – | – | ﹤0.01% | 2779 |
|
|
2021
Q2 | $217K | Hold |
15,391
| – | – | ﹤0.01% | 2885 |
|
|
2021
Q1 | $239K | Buy |
+15,391
| New | +$239K | ﹤0.01% | 2780 |
|
|
2020
Q4 | – | Sell |
-18,292
| Closed | -$221K | – | 3240 |
|
|
2020
Q3 | $221K | Hold |
18,292
| – | – | ﹤0.01% | 2740 |
|
|
2020
Q2 | $210K | Hold |
18,292
| – | – | ﹤0.01% | 2700 |
|
|
2020
Q1 | $249K | Sell |
18,292
-9,897
| -35% | -$135K | ﹤0.01% | 2467 |
|
|
2019
Q4 | $166K | Buy |
+28,189
| New | +$166K | ﹤0.01% | 2764 |
|
|
2017
Q4 | – | Sell |
-2,327
| Closed | -$124K | – | 3027 |
|
|
2017
Q3 | $124K | Sell |
2,327
-4,827
| -67% | -$257K | ﹤0.01% | 2745 |
|
|
2017
Q2 | $408K | Buy |
+7,154
| New | +$408K | ﹤0.01% | 2490 |
|
|
2017
Q1 | – | Sell |
-5,545
| Closed | -$324K | – | 3107 |
|
|
2016
Q4 | $324K | Buy |
+5,545
| New | +$324K | ﹤0.01% | 2595 |
|